All In Biotech

Drug Trial Radar · NCT06724900

A Study Assessing KB304 for the Treatment of Wrinkles in Women

A Phase 1/2 Study of KB304, a Replication-Defective, Non-Integrating Vector Expressing Human Type III Collagen (COL3) and Tropoelastin for the Treatment of Wrinkles

Last checked: Nov 19, 2026Latest source record: May 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

19

Actual

Start

Nov 20, 2024

Primary completion

Jul 2025

Study completion Aug 2025

Sponsor

Lead sponsor
Krystal Biotech, Inc.Industry
Sponsor type
Industry
First posted
Dec 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The aim of this study is to investigate the safety and efficacy of KB304, an investigational gene therapy to correct moderate to severe wrinkles in the décolleté region (V-shaped chest area). KB304 is an investigational gene therapy that delivers functional, full-length human collagen (COL3) and elastin (tropoelastin) to the skin through small injections using the Sponsor's genetically engineered Herpes Simplex Virus (HSV-1) vector. The study is a randomized double-blind study and participants will receive either KB304 (active group) or placebo (inactive group).

Conditions

  • Wrinkles in Decolletage
  • Pigmentation
  • Décolleté Wrinkles

Interventions

  • KB304Biological

    Genetically modified herpes simplex type 1 virus

  • 0.9% Normal Saline (NS)Drug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of KB304 versus placebo administered by intradermal injectionTime frame: Up to 4 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Steve Yoelin Medical Associates

    Newport Beach, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.